<div id="readability-page-1">Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics. Following the acquisition, the shares of Regulus ceased trading on the NASDAQ exchange, and the company became a fully owned subsidiary of Novartis. The acquisition marks a […]</div>

RGLS

諾華制藥

<p>諾華製藥已完成對 Regulus Therapeutics 的收購，交易金額為 17 億美元，並於 6 月 23 日確認了該交易。收購後，Regulus 的股票已停止在納斯達克交易，現在成為諾華的全資子公司。這一舉措使諾華成為歐洲頂級投資股票之一</p>

諾華製藥（NVS）以 17 億美元收購 Regulus Therapeutics